Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial

Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients

(2015) Shanshan Wu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

(2014) Mercedes Robles–Diaz et al.   GASTROENTEROLOGY

Potential protection of vitamin C against liver-lesioned mice

(2014) Min Su et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Global Epidemiology of Tuberculosis

(2014) P. Glaziou et al.   Cold Spring Harbor Perspectives in Medicine

Current Challenges and Controversies in Drug-Induced Liver Injury

(2013) Alberto Corsini et al.   DRUG SAFETY

Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law

(2013) Xin Shen et al.   DRUG SAFETY

Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China

(2013) H-Q. Pan et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Silymarin for HCV infection

(2012) Stephen J Polyak et al.   ANTIVIRAL THERAPY

Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study

(2012) Hee Kwon et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase

(2012) Hui-Min Xu   WORLD JOURNAL OF GASTROENTEROLOGY

Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)

(2011) Paul B. Watkins et al.   DRUG SAFETY

Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China

(2011) Penghui Shang et al.   PLoS One

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)

(2011) Helmi M’Kada et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Incidence, Clinical and Epidemiological Risk Factors, and Outcome of Drug-Induced Hepatitis Due to Antituberculous Agents in New Tuberculosis Cases

(2010) Parvaneh Baghaei et al.   AMERICAN JOURNAL OF THERAPEUTICS

Design of the Anti-tuberculosis Drugs induced Adverse Reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS)

(2010) Yin Yin Xia et al.   BMC PUBLIC HEALTH

Milk thistle in liver diseases: past, present, future

(2010) Ludovico Abenavoli et al.   PHYTOTHERAPY RESEARCH

Biomarkers for drug-induced liver injury

(2010) Qiang Shi et al.   Expert Review of Gastroenterology & Hepatology

Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study

(2009) Weiguo Xu et al.   BMC HEALTH SERVICES RESEARCH

Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach

(2008) Meghna R Adhvaryu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review

(2007) Alma Tostmann et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY